Claroty

Claroty was founded in 2015 and focuses on cybersecurity for operational technology (OT) and industrial control system (ICS) environments. The company is privately held, with its headquarters in New York and an R&D center in Israel.

Claroty's products address visibility and security for OT networks — industrial control systems, critical infrastructure, and connected medical devices (IoMT). The primary buyers are cybersecurity teams in industrial, energy, manufacturing, and healthcare organizations. The company sells through a direct sales model and channel partners.

Claroty's central platform is its Extended IoT Security offering, which provides asset discovery, network monitoring, and vulnerability management for OT and IoT environments. Following the acquisition of Medigate — an IoMT security company focused on healthcare networks — in 2023, Claroty expanded its coverage into the connected medical device segment.

The most prominent direct competitors in the OT security space include Dragos and Nozomi Networks. Claroty is positioned in the enterprise segment, targeting organizations with large and complex OT infrastructure.

Claroty's core R&D center is based in Israel and serves as the company's primary technology hub. The founders are Israeli with backgrounds in the cybersecurity domain.